Natural killer cells: development, maturation, and clinical utilization

AM Abel, C Yang, MS Thakar… - Frontiers in …, 2018 - frontiersin.org
Natural killer (NK) cells are the predominant innate lymphocyte subsets that mediate anti-
tumor and anti-viral responses, and therefore possess promising clinical utilization. NK cells …

Regulation of ligands for the activating receptor NKG2D

AR Mistry, CA O'Callaghan - Immunology, 2007 - Wiley Online Library
The outcome of an encounter between a cytotoxic cell and a potential target cell depends on
the balance of signals from inhibitory and activating receptors. Natural Killer group 2D …

[HTML][HTML] Single-cell RNA-seq reveals different subsets of non-specific cytotoxic cells in teleost

J Niu, Y Huang, X Liu, Z Zhang, J Tang, B Wang, Y Lu… - Genomics, 2020 - Elsevier
Non-specific cytotoxic cells (NCC) are important cytotoxic leukocytes in teleost immune
system. However, the NCC subsets have not been clarified. Thus, we create a …

NK cells encapsulated in micro/macropore-forming hydrogels via 3D bioprinting for tumor immunotherapy

D Kim, S Jo, D Lee, SM Kim, JM Seok, SJ Yeo… - Biomaterials …, 2023 - spj.science.org
Background Patients face a serious threat if a solid tumor leaves behind partial residuals or
cannot be completely removed after surgical resection. Immunotherapy has attracted …

Antibody: CD47 ratio regulates macrophage phagocytosis through competitive receptor phosphorylation

EC Suter, EM Schmid, AR Harris, E Voets, B Francica… - Cell reports, 2021 - cell.com
Cancer immunotherapies often modulate macrophage effector function by introducing either
targeting antibodies that activate Fcγ receptors (FcγRs) or blocking antibodies that disrupt …

[图书][B] Animal lectins: form, function and clinical applications

GS Gupta - 2012 - books.google.com
Animal Lectins: Form, Function and Clinical Applications presents up-to-date knowledge of
animal lectins. Detailed descriptions on biological activities, tissue and/or subcellular …

Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise

MP Bernard, S Bancos, PJ Sime… - Current pharmaceutical …, 2008 - ingentaconnect.com
There is much interest in the potential use of Cox-2 selective inhibitors in combination with
other cancer therapeutics. Malignancies of hematopoietic and non-hematopoietic origin …

Bloom syndrome patients and mice display accelerated epigenetic aging

J Lee, J Zhang, M Flanagan, JA Martinez, C Cunniff… - Aging …, 2023 - Wiley Online Library
Bloom syndrome (BSyn) is an autosomal recessive disorder caused by variants in the BLM
gene, which is involved in genome stability. Patients with BSyn present with poor growth …

IL-27 promotes NK cell effector functions via Maf-Nrf2 pathway during influenza infection

P Kumar, K Rajasekaran, A Nanbakhsh, J Gorski… - Scientific reports, 2019 - nature.com
Influenza virus targets epithelial cells in the upper respiratory tract. Natural Killer (NK) cell-
mediated early innate defense responses to influenza infection include the killing of infected …

Signaling in effector lymphocytes: insights toward safer immunotherapy

K Rajasekaran, MJ Riese, S Rao, L Wang… - Frontiers in …, 2016 - frontiersin.org
Receptors on T and NK cells systematically propagate highly complex signaling cascades
that direct immune effector functions, leading to protective immunity. While extensive studies …